| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Cabaletta Bio, Inc. (CABA) has 9 insiders with recent SEC Form 4 filings, including 8 buys and 4 sells. CABA is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 1.03M | $2.77M | - | |
| Dir | 147.2K | $396.0K | - | |
| Pres | 31.3K | $84.2K | - | |
| Dir | 22.7K | $61.1K | - | |
| Other | 22.2K | $59.6K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 21, 2026 | Simon Mark | Director | Buy | 11,061 | $2.28 | $25,261.11 | +8.1% | - | - | |
| Jan 21, 2026 | Nichtberger Steven | President &CEO | Buy | 45,000 | $2.24 | $100,777.50 | +4.6% | - | - | |
| Jan 21, 2026 | Bollard Catherine | Director | Buy | 4,405 | $2.27 | $9,982.17 | +440.5% | - | - | |
| Jan 21, 2026 | Tomasello Shawn | Director | Buy | 22,725 | $2.21 | $50,322.24 | New | - | - | |
| Jan 21, 2026 | Chang David J. | Chief Medical Officer | Buy | 8,800 | $2.26 | $19,888.00 | New | - | - | |
| Jan 21, 2026 | Binder Gwendolyn79 | President, Science &Tech. | Buy | 11,312 | $2.19 | $24,763.10 | +56.6% | - | - | |
| Jan 21, 2026 | Gavel Steve | Chief Commercial Officer | Buy | 22,170 | $2.27 | $50,215.05 | New | - | - | |
| Jan 21, 2026 | Gerard Michael | General Counsel | Buy | 6,600 | $2.27 | $14,979.36 | New | - | - | |
| Jan 19, 2024 | Binder Gwendolyn79 | See Remarks | Sale+OE | 11,000 | $19.59 | $215,439.12 | -21.3% | -28.3% | -85.9% | |
| Dec 19, 2023 | Binder Gwendolyn79 | See Remarks | Sale+OE | 11,000 | $21.89 | $240,789.23 | -20.3% | -19.6% | -89.8% |